New Delhi: In a grim milestone, India’s covid-19 tally on Saturday crossed 1 crore-mark. India on Saturday recorded 25,152 new coronavirus cases and 347 deaths, taking the total number of infected people and deaths since January to 10,004,599 and 1,41,5136 respectively, according to the Ministry of Health and Family Welfare’s data.
The difference between active cases and recovered cases is continuously widening. As many as 95,50,712 people have recovered while 3,08,751 people in the country are still infected with the disease.
India, which is world’s second worst affected country by the pandemic, has been recording the second-highest numbers of coronavirus cases in the world since August this year, following the US, which had crossed the milestone of one crore infections on November 9.
India also saw a massive spike in covid-19 cases in late August and September. The country recorded its highest single daily on September 16 with over 97,000 cases.
Notably, after that, number of cases have drastically come down since. As of now, the recovery rate is 95.46 per cent, while the death rate is 1.45 per cent.
India has highest recovery rate among all the countries affected by the covid-19 pandemic, the health ministry had said.
A total of 16,00,90,514 samples have been tested for Covid-19 till date. Of these, 11,71,868 samples were tested on Friday, said Indian Council of Medical Research (ICMR).
Maharashtra continues to be the worst-hit state in the country with 18,88,767 cases till date.
Kerala, West Bengal, Chhattisgarh, Uttar Pradesh, Delhi, Tamil Nadu, Madhya Pradesh, Rajasthan and Gujarat account for over 76 per cent of daily infections being reported.
Maharashtra, West Bengal, Delhi, Kerala, Uttar Pradesh, Haryana, Punjab, Tamil Nadu, Rajasthan and Chhattisgarh are credible for over 75 per cent of deaths, the Ministry added.
Meanwhile, in a major development, India has started gearing up for vaccination process. From releasing vaccination drive guidelines to training health care workers, the preparations to start vaccination are in full swing.
Three vaccine candidates have applied for emergency use authorisation from DCGI. It includes AstraZeneca and Oxford university developed and Serum Institute of India manufactured Covishield and Covaxin by Bharat Biotech Limited.